BioSpace News Archive

Center For Discovery brings anorexia, bulimia, binge eating, and other behavioral treatment to Austin, Texas

Join the Life Sciences division of AMPLEXOR at Booth #719 at this year’s DIA 2018 Global Annual Meeting.

Will Highlight the Increased Need for Innovation to Help Rethink and Reinvent the Consumer Health Care Experience

Zavation Medical Products announced that Brian K. Hutchison has joined its Board of Directors.

Cohere® interbody fusion study results now available in the Journal of Spine & Neurosurgery

CosmosID announced that the company’s cloud-based bioinformatics platform for microbiome analysis has received the highest score in the strain-level microbial profiling category of the Mosaic Community Challenge and for strain-level microbial identification in the precisionFDA Pathogen Detection Challenge

Companion Medical announced the launch of Insights by InPen™

Premier Inc. celebrated a decade of showcasing innovative products during its Innovation Celebration last night.

Hunterian Medicine LLC, has developed groundbreaking CRISPR delivery technology for which the United States Patent and Trademark Office has granted a patent (No. 9,907,863).

Acurx Pharmaceuticals, LLC (“Acurx” or the “Company”), a privately held clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections, today announced that the U.S. Food and Drug Administration (FDA) has designated the Company’s lead antibiotic product candidate, ACX-362E, as a Qualified Infectious Disease Product (QIDP).